Blood Products Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030

Market Overview

Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Several blood components are isolated from the total blood in such circumstances. Platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products are among the blood products available. An individual is given a specific blood product depending on their condition. Blood is an extremely important bodily fluid that ensures the proper functioning of organs. However, there are a variety of chronic medical problems that cause the body's red blood cell count to drop. Diseases like leukemia, cancer, and end-stage renal disease, for example, cause significant consequences that necessitate blood transfusions.

Blood Products Market: Key Players

• Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• American Red Cross
• America`s Blood Centers
• BPL Inc.
• CSL
• Mitsubishi Tanabe Pharma Corporation
• Bharat Serums and Vaccines Ltd.
• Bio Products Laboratory Ltd.
• Kedrion S.p.A
• Bio-Rad Laboratories, Inc.
• Octapharma AG
• Canadian Blood Services

Growth Factor

Rise in geriatric population

According to the World Health Organization, the worldwide population of people aged 60 and over will nearly double from 12 percent to 22 percent between 2015 and 2050, with 80 percent of the aging population residing in low- and middle-income nations. The world's ageing population may result in a rise in illnesses that require plasma treatment. As a result, the market will develop faster as the senior population grows.

Segmentation

• By Product Type
  • Platelets
  • Fresh Frozen Plasma (FFP)
  • Red Blood Cells (RBCs)
  • White Blood Cells (WBCs)
  • Others
• By End-User
  • Hospitals
  • Blood Station
  • Others
• Blood Products Market Dynamics
• Blood Products Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Recent News Related to Market

1. North America is the market leader for blood plasma products, accounting for 44.2 percent of the market in 2018. This is owing to the increased prevalence of hemophilia and the FDA's quick approval of plasma products.
2. In October 2018, The FDA revised its criteria on dried plasma products for blood transfusion, including everything from the best sources of input plasma to device submissions.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

• COVID-19 pre and post business impact analysis
• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• What is the Blood Products Market growth?
• Which segment accounted for the largest Blood Products Market share?
• Who are the key players in the Blood Products Market?
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.